Company
Thryv Therapeutics
Relentlessly pursuing treatments for cardiac conditions.
Also known as Thryv Therapeutics Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Thryv Therapeutics Inc.
- thryvtrx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Thryv Therapeutics is a clinical-stage biotech pioneering precision medicine approaches to treating genetic arrhythmia syndromes and acquired cardiometabolic diseases through potent and selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1).
Loading relationship preview